Search results
'Cybersecurity incident' closes London Drugs' pharmacies
The Register· 18 minutes agoCanadian pharmacy chain London Drugs has closed all of its stores until further notice following a...
Young people blocked from 'life-saving' cancer trials
BBC via AOL· 11 hours agoSome young people are being unfairly denied access to cancer trials [PA] Young people with cancer...
Pipeline Moves: Investigator-led trial of Lilly’s merestinib in solid tumours terminated
Clinical Trials Arena via Yahoo Finance· 11 hours agoThe drug’s PTSR decreased by 11 points to 34% in bile duct cancer, 10 points to 35% in gallbladder ...
FDA approves bladder cancer treatment by Culver City company
LA Times via Yahoo News· 7 days agoThe Food and Drug Administration has approved Culver City-based ImmunityBio's treatment for bladder ...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
WSAU Wausau· 4 days agoBy Patrick Wingrove (Reuters) - Merck & Co on Thursday raised its annual profit and revenue forecast...
FDA Releases Final Rule on Regulation of Laboratory-Developed Tests
GenomeWeb News· 4 hours agoThe US Food and Drug Administration released on Monday its final rule to regulate...
Cancer drug trial provides lessons for future
Medical Xpress· 4 days agoA cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal ...
...BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of HERCESSI™...Several Forms...
KTLA-TV Los Angeles· 7 hours agoFood and Drug Administration (FDA) has approved HERCESSI™ (trastuzumab-strf), a biosimilar to Herceptin® (trastuzumab), to treat HER2-overexpressing breast and gastric or ...
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Reuters via AOL· 4 days ago(Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecast on the back of...
Patient, 59, 'at death's door' before cancer drug ‘eradicated’ disease in months
The US Sun· 6 days agoA MAN "at death's door" after running out of treatment options for leukaemia became the second...